These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7069779)

  • 1. Competition for immune complexes by red cells in human blood.
    Medof ME; Oger JJ
    J Clin Lab Immunol; 1982 Jan; 7(1):7-13. PubMed ID: 7069779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.
    Medof ME; Prince GM; Oger JJ
    Clin Exp Immunol; 1982 Jun; 48(3):715-25. PubMed ID: 7116690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complex alterations occur on the human red blood cell membrane.
    Medof ME; Prince GM
    Immunology; 1983 Sep; 50(1):11-8. PubMed ID: 6224741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of normal interactions between immune complexes and systemic lupus erythematosus blood cells by normal serum.
    Medof ME; Oger JJ; Antel JP; Prince GM
    J Clin Lab Immunol; 1982 Feb; 7(2):93-103. PubMed ID: 7069786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
    Taylor RP; Burge J; Horgan C; Shasby DM
    J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells.
    Varga L; Thiry E; Füst G
    Immunology; 1988 Jul; 64(3):381-4. PubMed ID: 3410490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
    Edberg JC; Wright E; Taylor RP
    J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W; Burdick G; Carl V; Lachmann PJ
    J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
    Horgan C; Burge J; Crawford L; Taylor RP
    J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y; Tamura N; Fujita T
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
    Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
    Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer.
    Arnaout MA; Melamed J; Tack BF; Colten HR
    J Immunol; 1981 Oct; 127(4):1348-54. PubMed ID: 7276561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets.
    Taylor RP; Kujala G; Wilson K; Wright E; Harbin A
    J Immunol; 1985 Apr; 134(4):2550-8. PubMed ID: 3919101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative pathway-mediated rebinding of immune complexes to human red blood cells.
    Medof ME; Prince GM
    Immunology; 1983 Sep; 50(1):1-9. PubMed ID: 6411608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of immune complexes to human red cells: complement requirements and fate of the RBC-bound IC after interaction with human phagocytic cells.
    Sherwood TA; Virella G
    Clin Exp Immunol; 1986 Apr; 64(1):195-204. PubMed ID: 3731526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of complement to release systemic lupus erythematosus immune complexes from cell receptors.
    Medof ME; Scarborough D; Miller G
    Clin Exp Immunol; 1981 May; 44(2):416-25. PubMed ID: 7307341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for human red blood cells in inactivation of C3b in immune complexes and enhancement of binding to spleen cells.
    Medof ME; Lam T; Prince GM; Mold C
    J Immunol; 1983 Mar; 130(3):1336-40. PubMed ID: 6218206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a C3b/iC3 binding protein of rabbit platelets and leukocytes. A CR1-like candidate for the immune adherence receptor.
    Manthei U; Nickells MW; Barnes SH; Ballard LL; Cui WY; Atkinson JP
    J Immunol; 1988 Feb; 140(4):1228-35. PubMed ID: 2963863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of Beta 1H and is accompanied by generation of C3c.
    Medof ME; Prince GM; Mold C
    Proc Natl Acad Sci U S A; 1982 Aug; 79(16):5047-51. PubMed ID: 6214790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.